[Skip to Navigation]
Comment & Response
August 2017

Histiocytoid Sweet Syndrome and Myelodysplastic Syndrome—Reply

Author Affiliations
  • 1Department of Dermatology, Fundación Jiménez Díaz, Universidad Autónoma, Madrid, Spain
  • 2Department of Dermatology, Medical University of Graz, Graz, Austria
JAMA Dermatol. 2017;153(8):836-837. doi:10.1001/jamadermatol.2017.1670

In Reply We appreciate the interest of Vignon-Pennamen et al in our study1 on histiocytoid Sweet syndrome (HSS). Like us, they consider the cells of the infiltrate as immature myeloid cells rather than M2 macrophages, and for them, too, this histopathologic variant of Sweet syndrome should not be considered a form of leukemia cutis; these were the 2 main goals of our study.

Add or change institution